Article Information
History
- April 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mark P. Breazzano, MD1,2,3,
- Junchao Shen, BS4,
- Aliaa H. Abdelhakim, MD1,2,3,
- Lora R. Dagi Glass, MD1,
- Jason D. Horowitz, MD1,
- Sharon X Xie, PhD5,
- C. Gustavo de Moraes, MD1,
- Alice Chen-Plotkin, MD4,
- Royce W. S. Chen, MD1,* and
- on behalf of the New York City Residency Program Directors COVID-19 Research Group
- 1Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA
- 2Department of Ophthalmology, New York University School of Medicine, New York University Langone Health, New York, NY, USA
- 3Manhattan Eye, Ear and Throat Hospital, Lenox Hill Hospital, Northwell Health, New York, NY, USA
- 4Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
- 5Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
- ↵*CORRESPONDENCE:
Royce W. S. Chen, M.D., Helen and Martin Kimmel Assistant Professor of Clinical Ophthalmology, Divisions of Vitreoretinal Surgery and Uveitis, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 635 W 165th St, New York, NY 10032, Tel: 212-305-9535, Fax: 212-305-5523, Email: rc2631{at}cumc.columbia.edu
Posted April 28, 2020.
Resident physician exposure to novel coronavirus (2019-nCoV, SARS-CoV-2) within New York City during exponential phase of COVID-19 pandemic: Report of the New York City Residency Program Directors COVID-19 Research Group
